Seasonal variation in human brain serotonin transporter binding

Archives of General Psychiatry

Volumn 65, Issue 9, 2008, Pages 1072-1078

  Praschak Rieder, Nicole ^a,c,d   Willeit, Matthaeus ^a,c,d   Wilson, Alan A ^a,c   Houle, Sylvain ^a,c   Meyer, Jeffrey H ^a,b,c,e  

^a Vivian M Rakoff PET Imaging Centre   (Canada)

^b START Clinic for Mood and Anxiety Disorders   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING; SEASONAL VARIATION;

ADULT; BINDING SITES; BRAIN; FEMALE; HUMANS; LIGHT; MALE; MIDDLE AGED; SEASONS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPSES; TIME FACTORS;

EID: 50949085682     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.65.9.1072     Document Type: Article

References (71)

1. Balzer I, Hardeland R. Circadian rhythmicity in the stimulation of bioluminescence by biogenic amines and MAO inhibitors in Gonyaulax polyedra. Int J Biometeorol. 1991;34(4):231-234.
2. Wehr TA, Duncan WC Jr, Sher L,Aeschbach D, Schwartz PJ, Turner EH, Postolache TT, Rosenthal NE. A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry. 2001;58(12):1108-1114.
3. Kasper S, Wehr TA, Bartko JJ, Gaist PA, Rosenthal NE. Epidemiological findings of seasonal changes in mood and behavior: a telephone survey of Montgomery County, Maryland. Arch Gen Psychiatry. 1989;46(9):823-833.
4. Hardin TA, WehrTA, Brewerton T, Kasper S, Berrettini W, Rabkin J, Rosenthal NE. Evaluation of seasonality in six clinical populations and two normal populations. J Psychiatr Res. 1991;25(3):75-87.
5. Harris S, Dawson-Hughes B. Seasonal mood changes in 250 normal women. Psychiatry Res. 1993;49(1):77-87.
6. Okawa M, Shirakawa S, Uchiyama M, Oguri M, Kohsaka M, Mishima K, Sakamoto K, Inoue H, Kamei K, Takahashi K. Seasonal variation of mood and behaviour in a healthy middle-aged population in Japan. Acta Psychiatr Scand. 1996; 94(4):211-216.
7. Hegde AL, Woodson H. Prevalence of seasonal changes in mood and behavior during the winter months in central Texas. Psychiatry Res. 1996;62(3):265-271.
8. Rohan KJ, Sigmon ST. Seasonal mood patterns in a northeastern college sample. J Affect Disord. 2000;59(2):85-96.
9. Perry JA, Silvera DH, Rosenvinge JH, Neilands T, Holte A. Seasonal eating patterns in Norway: a non-clinical population study. Scand J Psychol. 2001;42 (4):307-312.
10. Chotai J, Smedh K, Johansson C, Nilsson LG, Adolfsson R. An epidemiological study on gender differences in self-reported seasonal changes in mood and behaviour in a general population of northern Sweden. Nord J Psychiatry. 2004; 58(6):429-437.
11. Friedman E, Gyulai L, Bhargava M, Landen M, Wisniewski S, Foris J, Ostacher M, Medina R,Thase M. Seasonal changes in clinical status in bipolar disorder: a prospective study in 1000 STEP-BD patients. Acta Psychiatr Scand. 2006;113(6): 510-517.
12. 3H]citalopram platelet binding between healthy controls and violent offenders in Finland. Hum Psychopharmacol. 2005;20(7):467-472.
13. Maes M, Scharpe S, Verkerk R, D'Hondt P, Peeters D, Cosyns P, Thompson P, De Meyer F, Wauters A, Neels H. Seasonal variation in plasma L-tryptophan availability in healthy volunteers: relationships to violent suicide occurrence. Arch Gen Psychiatry. 1995;52(11):937-946.
14. Sarrias MJ, Artigas F, Martinez E, Gelpi E. Seasonal changes of plasma serotonin and related parameters: correlation with environmental measures. Biol Psychiatry. 1989;26(7):695-706.
15. Carlsson A, Svennerholm L, Winblad B. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl. 1980; 280:75-85.
16. Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet. 2002;360(9348):1840-1842.
17. Rudnick G, Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta. 1993;1144(3):249-263.
18. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, lida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27(9):1533-1539.
19. 11C]McN5652and [11C]DASB. Neuropsychopharmacology. 2005;30(9):1741-1750.
20. Meyer JH. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci. 2007;32(2):86-102.
21. 123l]-2β- carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry. 2000;47(2):158-160.
22. Buchert R, Schulze O, Wilke F, Berding G, Thomasius R, Petersen K, Brenner W, Clausen M. Is correction for age necessary in SPECT or PET of the central serotonin transporter in young, healthy adults? J Nucl Med. 2006;47(1):38-42.
23. 11C]McN5652. J Cereb Blood Flow Metab. 2002; 22(4):490-501.
24. 11C-labeled 2-(phenylthio) araalkylamines. J Med Chem. 2000;43(16):3103-3110.
25. Frankle WG, Huang Y, Hwang DR, Talbot PS, Slifstein M, Van Heertum R, AbiDargham A, Laruelle M. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. J Nucl Med. 2004; 45(4):682-694.
26. 11C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab. 2001;21(11):1342-1353.
27. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23(9):1096-1112.
28. 11C]AFM. J Cereb Blocd Flow Metab. 2002;22(11):1377-1398.
29. First M, Spitzer R, Williams J, Gibbon M. Structured Clinical Interview for DSM-IV-Non-Patient Edition (SCID-NP, Version 1.0). Washington, DC: American Psychiatric Press; 1995.
30. 11C]DASB. Eur J Nucl Med. 2000;27(11):1719-1722.
31. 11C]DASB PET imaging study. Am J Psychiatry. 2001; 158(11):1843-1849.
32. Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, Goulding V, Kennedy J, Wilson AA. Brain serotonin transporter binding potential measured with carbon 11 -labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry. 2004;61(12):1271-1279.
33. 11C]DASB positron emission tomography study. Am J Psychiatry. 2004;161(5):826-835.
34. Praschak-Rieder N, Wilson AA, Hussey D, Carella A, Wei C, Ginovart N, Schwarz MJ, Zach J, Houle S, Meyer JH. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol Psychiatry. 2005;58(10):825-830.
35. 11C] DASB positron emission tomography study. Biol Psychiatry. 2007;62(4):327-331.
36. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood flow Metab. 1996;16(5):834-840.
37. Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab. 2002;22(12): 1440-1452.
38. 123l]beta- CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse. 2001;41 (4):275-284.
39. Bel N, Artigas F. Fluvoxamine preferentially increases extracellular 5-hydroxy-tryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol. 1992;229(1):101-103.
40. Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM. Gene dose-dependent alterations in extraneuronal serotonin but notdopamine in mice with reduced serotonin transporter expression. J Neurosci Methods. 2004; 140(1-2):169-181.
41. Shen HW, Hagino Y, Kobayashi H.Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch KP, Murphy DL, Hall FS, Uhl GR, Sora I. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology. 2004; 29(10):1790-1799.
42. Jennings KA, Loder MK, Sheward WJ, Pei Q, Deacon RM, Benson MA, Olver-man HJ, Hastie ND, Harmar AJ, Shen S, Sharp T. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci. 2006;26(35):8955-8964.
43. Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA, Houle S. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry. 2006;63(11):1209-1216.
44. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA. Seasonal affective disorder: a description of the syn-drome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984; 41(1):72-80.
45. Penev PD, Zee PC, Turek FW. Serotonin in the spotlight [letter]. Nature. 1997;385 (6612):123.
46. 3H]imipramine binding and serotonin uptake in the rat brain. J Neurochem. 1989;52(2):507-514.
47. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther. 1997;283(3):1305-1322.
48. Tatsumi M, Groshan K, Blakely RD. Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340(2-3):249-258.
49. 11C-DASB in healthy humans. Synapse. 2005;55(3):164-175.
50. 11C]- DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse. 2003;47(2):123-133.
51. 11C] DASB for measuring endogenous serotonin with PET: binding studies. Nucl Med Biol. 2005;32(2):129-136.
52. Celada P, Artigas F. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei: a brain microdialysis study in the awake rat. Naunyn Schmiedebergs Arch Pharmacol. 1993;347 (6):583-590.
53. Malyszko J, Urano T, Serizawa K, Yan D, Kozima Y, Takada Y, Takada A. Serotonergic measures in blood and brain and their correlations in rats treated with tranylcypromine, a monoamine oxidase inhibitor. Jpn J Physiol. 1993;43(5): 613-626.
54. Blakely R, Ramamoorthy S, Qian Y, Schroeter S. Regulation of antidepressant-sensitive serotonin transporters. In: Reith M, ed. Neurotransmitter Transporters: Structure, Function, and Regulation. Totowa, NJ: Humana Press Inc; 1997: 29-72.
55. Kennaway DJ, Moyer RW. Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms. Brain Res. 1998;806(2):257-270.
56. Moyer RW, Kennaway DJ. Serotonin depletion decreases light induced c-fos in the rat suprachiasmatic nucleus. Neuroreport. 2000;11(5):1021-1024.
57. Moyer RW, Kennaway DJ, Ferguson SA, Dijstelbloem YP. Quipazine and light have similar effects on c-fos induction in the ratsuprachiasmatic nucleus. Brain Res. 1997;765(2):337-342.
58. Durkheim E. Le suicide: etude de sociologie. Paris. France: Presses Universitaires de France: 1897.
59. Chew KS, McCleary R. The spring peak in suicides: a cross-national analysis. Soc Sci Med. 1995;40(2):223-230.
60. Rocchi MB. Perlini C. Is the time of suicide a random choice? a new statistical perspective. Crisis. 2002;23(4):161-166.
61. Partonen T, Haukka J, Viilo K, Hakko H, Pirkola S, Isometsa E, Lonnqvist J, Sarkioja T, Vaisanen E, Rasanen P. Cyclic time patterns of death from suicide in northern Finland. J Affect Disord. 2004;78(1):11-19.
62. Björkstén KS. Bjerregaard P. Kripke DF. Suicides in the midnight sun: a study of seasonality in suicides in West Greenland. Psychiatry Res. 2005;133(2-3): 205-213.
63. Heerlein A, Valeria C, Medina B. Seasonal variation in suicidal deaths in Chile: its relationship to latitude. Psychopathology. 2006;39(2):75-79.
64. Parker G. Gao F, Machin D. Seasonality of suicide in Singapore: data from the eguator. Psychol Med. 2001;31(3):549-553.
65. Artigas F, Romero L, de Montigny C, Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 1996;19(9):378-383.
66. Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation: a possible prelude to violence. Science. 2000;289(5479):591-594.
67. Stockmeier CA. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res. 2003;37(5):357-373.
68. 11C]DASB is affected by serotonin transporter genotype. J Neural Transm. 2007;114(5):635-639.
69. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301(5631):386-389.
70. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry. 2005;62(5): 529-535.
71. Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A, Blair IP, Parker G, Schofield PR. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry. 2006;188:210-215.